Andere Sprachen IDEXX Laboratories, Inc.

Aktien

888210

US45168D1046

IDXX

Medizinische Versorgung

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 05.12.2025			% 5 Tage	Veränd. 1. Jan.
714,10 ^USD	-0,47 %		-5,15 %	+72,72 %

10.11.	Idexx Laboratories: Insider verkauft Aktien im Wert von 6.629.014 US-Dollar laut aktueller SEC-Meldung	MT
10.11.	IDEXX LABORATORIES, INC. : Piper Sandler bekräftigt seine neutrale Bewertung	ZM

Andere Sprachen

Idexx Laboratories, Inc. Announces Amendment No. 2 to Fourth Amended and Restated Credit Agreement	13.11.
Idexx Laboratories Insider Sold Shares Worth $6,629,014, According to a Recent SEC Filing	10.11.
Nasdaq, S&P 500 Rise in Mixed Session as Amazon Leads Tech Advance	03.11.
US Equity Indexes Mixed as Amazon's Gains Help S&P 500, Nasdaq Outperform Dow	03.11.
Tranche Update on IDEXX Laboratories, Inc.'s Equity Buyback Plan announced on August 13, 1999.	03.11.
US Equity Markets Close Mixed as Amazon Rises on OpenAI Deal Amid Market Decline	03.11.
Sector Update: Health Care Stocks Softer Late Afternoon	03.11.
Sector Update: Health Care	03.11.
IDEXX relève ses prévisions annuelles après un solide trimestre porté par la demande en soins préventifs	03.11.
IDEXX Laboratories, Inc. Revises Earnings Guidance for the Year 2025	03.11.
Equities Mostly Rise Intraday Amid Amazon Boost as Markets Await Week's Key Earnings	03.11.
US Equity Indexes Mixed as Amazon Helps Consumer Discretionary, Technology Buck Declining Trend	03.11.
IDEXX raises annual forecasts on strong demand for pet diagnostics, shares surge	03.11.
Sector Update: Health Care Stocks Lower Pre-Bell Monday	03.11.
Sector Update: Health Care	03.11.
IDEXX Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	03.11.
IDEXX raises annual forecasts as pet owners spend more on preventive care	03.11.
Stocks Gain Pre-Bell as Traders Eye Strong Start to November, Await More Earnings	03.11.
IDEXX Laboratories Q3 Earnings, Revenue Rise; Raises 2025 Guidance	03.11.
Idexx: Q3 Earnings Snapshot	03.11.
Veterinary diagnostics company beats IDEXX Q3 revenue estimates, hikes FY forecasts	03.11.
(IDXX) IDEXX Laboratories Expects 2025 Revenue Range $4.27B to $4.30B, vs. FactSet Est of $4.24B	03.11.
(IDXX) IDEXX Laboratories Expects 2025 EPS Range $12.81 - $13.01, vs. FactSet Est of $12.62	03.11.
Earnings Flash (IDXX) IDEXX Laboratories, Inc. Reports Q3 Revenue $1.11B, vs. FactSet Est of $1.07B	03.11.
Earnings Flash (IDXX) IDEXX Laboratories Posts Q3 Comparable EPS $3.22, vs. FactSet Est of $3.12	03.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen IDEXX Laboratories, Inc.

Aktien

888210

US45168D1046

IDXX

Medizinische Versorgung

Andere Sprachen

Filter